Mesenchymal Stromal/Stem Cells and Their Extracellular Vesicles Application in Acute and Chronic Inflammatory Liver Diseases: Emphasizing on the Anti-Fibrotic and Immunomodulatory Mechanisms

被引:32
作者
Hazrati, Ali [1 ]
Malekpour, Kosar [2 ]
Soudi, Sara [1 ]
Hashemi, Seyed Mahmoud [3 ]
机构
[1] Tarbiat Modares Univ, Fac Med Sci, Dept Immunol, Tehran, Iran
[2] Iran Univ Med Sci, Sch Med, Dept Immunol, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Sch Med, Dept Immunol, Tehran, Iran
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
关键词
MSCs; exosomes; liver disease; immunomodulation; inflammation; regeneration; HEPATIC STELLATE CELLS; SINUSOIDAL ENDOTHELIAL-CELLS; STEM-CELLS; STERILE INFLAMMATION; REPERFUSION INJURY; IN-VIVO; FIBROSIS; FAILURE; TRANSPLANTATION; ACTIVATION;
D O I
10.3389/fimmu.2022.865888
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Various factors, including viral and bacterial infections, autoimmune responses, diabetes, drugs, alcohol abuse, and fat deposition, can damage liver tissue and impair its function. These factors affect the liver tissue and lead to acute and chronic liver damage, and if left untreated, can eventually lead to cirrhosis, fibrosis, and liver carcinoma. The main treatment for these disorders is liver transplantation. Still, given the few tissue donors, problems with tissue rejection, immunosuppression caused by medications taken while receiving tissue, and the high cost of transplantation, liver transplantation have been limited. Therefore, finding alternative treatments that do not have the mentioned problems is significant. Cell therapy is one of the treatments that has received a lot of attention today. Hepatocytes and mesenchymal stromal/stem cells (MSCs) are used in many patients to treat liver-related diseases. In the meantime, the use of mesenchymal stem cells has been studied more than other cells due to their favourable characteristics and has reduced the need for liver transplantation. These cells increase the regeneration and repair of liver tissue through various mechanisms, including migration to the site of liver injury, differentiation into liver cells, production of extracellular vesicles (EVs), secretion of various growth factors, and regulation of the immune system. Notably, cell therapy is not entirely excellent and has problems such as cell rejection, undesirable differentiation, accumulation in unwanted locations, and potential tumorigenesis. Therefore, the application of MSCs derived EVs, including exosomes, can help treat liver disease and prevent its progression. Exosomes can prevent apoptosis and induce proliferation by transferring different cargos to the target cell. In addition, these vesicles have been shown to transport hepatocyte growth factor (HGF) and can promote the hepatocytes'(one of the most important cells in the liver parenchyma) growths.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] Mesenchymal stromal/stem cells and their extracellular vesicles in liver diseases: insights on their immunomodulatory roles and clinical applications
    Huai, Qian
    Zhu, Cheng
    Zhang, Xu
    Dai, Hanren
    Li, Xiaolei
    Wang, Hua
    CELL AND BIOSCIENCE, 2023, 13 (01)
  • [2] Anti-fibrotic and anti-inflammatory effect of mesenchymal stromal cell-derived extracellular vesicles in chronic kidney disease
    Chiabotto, Giulia
    Bruno, Stefania
    BIOCELL, 2023, 47 (07) : 1499 - 1508
  • [3] Anti-fibrotic mechanisms of exogenously-expanded mesenchymal stromal cells for fibrotic diseases
    Rockel, Jason S.
    Rabani, Razieh
    Viswanathan, Sowmya
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2020, 101 : 87 - 103
  • [4] Mesenchymal stromal/stem cells and their extracellular vesicles in liver diseases: insights on their immunomodulatory roles and clinical applications
    Qian Huai
    Cheng Zhu
    Xu Zhang
    Hanren Dai
    Xiaolei Li
    Hua Wang
    Cell & Bioscience, 13
  • [5] Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cells and Extracellular Vesicles: Therapeutic Outlook for Inflammatory and Degenerative Diseases
    Dabrowska, Sylwia
    Andrzejewska, Anna
    Janowski, Miroslaw
    Lukomska, Barbara
    FRONTIERS IN IMMUNOLOGY, 2021, 11
  • [6] Effects of Extracellular Vesicles Derived from Mesenchymal Stem/Stromal Cells on Liver Diseases
    Zheng, Wenjie
    Yang, Yumin
    Sequeira, Russel Clive
    Bishop, Colin E.
    Atala, Anthony
    Gu, Zhifeng
    Zhao, Weixin
    CURRENT STEM CELL RESEARCH & THERAPY, 2019, 14 (05) : 442 - 452
  • [7] Extracellular vesicles derived from mesenchymal stem/stromal cells: The regenerative impact in liver diseases
    Psaraki, Adriana
    Ntari, Lydia
    Karakostas, Christos
    Korrou-Karava, Despoina
    Roubelakis, Maria G.
    HEPATOLOGY, 2022, 75 (06) : 1590 - 1603
  • [8] Extracellular Vesicles Are More Potent Than Adipose Mesenchymal Stromal Cells to Exert an Anti-Fibrotic Effect in an In Vitro Model of Systemic Sclerosis
    Rozier, Pauline
    Maumus, Marie
    Bony, Claire
    Maria, Alexandre Thibault Jacques
    Sabatier, Florence
    Jorgensen, Christian
    Guilpain, Philippe
    Noel, Daniele
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (13)
  • [9] Anti-Inflammatory and Anti-Fibrotic Effects of Human Amniotic Membrane Mesenchymal Stem Cells and Their Potential in Corneal Repair
    Navas, Alejandro
    Sofia Magana-Guerrero, Fatima
    Dominguez-Lopez, Alfredo
    Chavez-Garcia, Cesar
    Partido, Graciela
    Graue-Hernandez, Enrique O.
    Javier Sanchez-Garcia, Francisco
    Garfias, Yonathan
    STEM CELLS TRANSLATIONAL MEDICINE, 2018, 7 (12) : 906 - 917
  • [10] Comparative Evaluation of Anti-Fibrotic Effect of Tissue Specific Mesenchymal Stem Cells Derived Extracellular Vesicles for the Amelioration of CCl4 Induced Chronic Liver Injury
    Gupta, Suchi
    Pinky
    Vishay
    Sharma, Harshita
    Soni, Naina
    Rao, E. Pranshu
    Dalela, Manu
    Yadav, Alka
    Nautiyal, Nidhi
    Kumar, Anupam
    Nayak, Baibaswata
    Banerjee, Arup
    Dinda, Amit Kumar
    Mohanty, Sujata
    STEM CELL REVIEWS AND REPORTS, 2022, 18 (03) : 1097 - 1112